Return to Article Details
COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA
Download
Download PDF